Cadrenal Therapeutics, Inc. Common Stock
Symbol: CVKD (NASDAQ)
10.35
▼ (-0.67%) -0.070
Company Description:
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
Key Stats
- Today's Open: $10.35
- Today's High: $10.37
- Today's Low: $10.31
- Today's Volume: 2.38K
- Yesterday Close: $10.42
- Yesterday High: $10.6
- Yesterday Low: $10.0747
- Yesterday Volume: 31.92K
- Last Min Volume: 1
- Last Min High: $10.35
- Last Min Low: $10.35
- Last Min VWAP: $10.35
Company Profile
- Name: Cadrenal Therapeutics, Inc. Common Stock
- Website: https://www.cadrenal.com
- Listed Date: 2023-01-20
- Location: PONTE VEDRA, FL
- Market Status: Active
- CIK Number: 0001937993
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $20.32M
- Round Lot: 100
- Outstanding Shares: 1.97M
- Asset Type: CS
RECENT FILINGS FOR CVKD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-31 | ARS | View |
| 2025-07-31 | DEFA14A | View |
| 2025-07-31 | DEF 14A | View |
| 2025-07-18 | 8-K | View |
| 2025-05-08 | 8-K | View |
| 2025-05-08 | 10-Q | View |
| 2025-04-17 | 8-K | View |
| 2025-04-17 | 424B5 | View |
| 2025-03-24 | 4/A | View |
| 2025-03-13 | 8-K | View |
| 2025-03-13 | 10-K | View |
| 2025-03-04 | 8-K | View |
| 2025-02-12 | SCHEDULE 13G/A | View |
| 2025-02-07 | 8-K | View |
| 2025-02-06 | 4 | View |
| 2025-02-06 | 3 | View |
| 2025-02-03 | S-8 | View |
| 2025-01-29 | SCHEDULE 13D | View |
| 2025-01-24 | 4 | View |
| 2025-01-24 | 4 | View |
Latest News on CVKD